Tedizolid Suppressive Antimicrobial Therapy in a Reference Center

NCT04662736 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2021-06-21

No results posted yet for this study

Summary

the aim of the study is to describe the management and outcome of patients having an osteo-articular infection treated by tedizolid as a suppressive antibiotic therapy.

Conditions

  • Bone and Joint Infection

Interventions

OTHER

patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic therapy

description of osteo-articular infection managed with tedizolid as a suppressive antibiotic therapy

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2021-02-01
Completion
2021-04-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04662736 on ClinicalTrials.gov